how do glp-1 agonists work Frontiers GLP-1 Agonist-based Therapies: An Emerging

Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.

This approach highlights how nutritional substrates and metabolic cofactors may influence physiological resilience during sustained pharmacological weight reduction

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity

Andrew Stokes received a grant from the Robert Wood Johnson Foundation analyze the real-word effects of this new class of appetite-suppressing therapies, as well as inequities in access to these medications.

Study Selection We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study